Susquehanna Fundamental Investments, LLC Avrobio, Inc. Transaction History

Susquehanna Fundamental Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.68 - $1.11 $15,959 - $26,051	-23,470 Reduced 25.43%	68,826 $44,000
Q1 2022 May 16, 2022	BUY	$1.29 - $4.04 $77,263 - $241,971	59,894 Added 184.85%	92,296 $122,000
Q4 2021 Feb 14, 2022	BUY	$3.45 - $6.05 $111,786 - $196,032	32,402 New	32,402 $125,000
Q3 2021 Nov 15, 2021	SELL	$5.53 - $9.28 $134,567 - $225,819	-24,334 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$7.84 - $12.6 $190,778 - $306,608	24,334 New	24,334 $216,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.